The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 24, 2020

Filed:

Oct. 15, 2019
Applicant:

IN Ingredients, Inc., Spring Hill, TN (US);

Inventors:

Augustin T. Romero, Columbia, TN (US);

Bolin Qin, Gaithersburg, MD (US);

Assignee:

IN Ingredients, Inc., Spring Hill, TN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/00 (2006.01); A61K 31/357 (2006.01); A61K 36/53 (2006.01); A61K 36/9066 (2006.01); A61K 36/63 (2006.01); A61K 36/73 (2006.01); A61K 31/353 (2006.01); A61K 31/7048 (2006.01); A61K 36/49 (2006.01); A61K 36/54 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/357 (2013.01); A61K 31/353 (2013.01); A61K 31/7048 (2013.01); A61K 36/49 (2013.01); A61K 36/53 (2013.01); A61K 36/54 (2013.01); A61K 36/63 (2013.01); A61K 36/73 (2013.01); A61K 36/9066 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01);
Abstract

Processes for treating an autoimmune disease or condition by decreasing expression of a CD274 gene and/or a PD-L1 protein and increasing expression of a PDCD1 gene and/or a PD-1 protein in a subject in need of such expression changes are provided. The processes include administering to the subject a composition including at least 0.5% of cinnamtannin D-1 and/or cinnamtannin B-1. The processes further include decreasing expression of a CD274 gene and/or a PD-L1 protein and increasing expression of a PDCD1 gene and/or a PD-1 protein in the subject by the step of administering at the desired concentration or for the desired time wherein the composition may increase or decrease the relative expression levels of the genes or proteins while simultaneously ameliorating, preventing, or modulating a cardiac event in the subject.


Find Patent Forward Citations

Loading…